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Ambient pressure upregulates nitric oxide synthase
in a phosphorylated-extracellular regulated kinase–
and protein kinase C–dependent manner
Angela G. Vouyouka, MD,b Yan Jiang, MS,a Ruchi Rastogi, MSc,a and Marc D. Basson, MD, PhD,a
Detroit, Mich
Purpose:Using endothelial cell/smooth muscle cell (SMC) cocultures, we have demonstrated that pressurized endothelial
cell coculture inhibits SMC proliferation and promotes apoptosis, and that this effect is transferable through pressurized
endothelial medium. We now hypothesized that endothelial nitric oxide synthase (eNOS) plays a significant role in
mediating these pressure-induced effects.
Methods:Conditioned media from endothelial cells and SMCs exposed to ambient and increased pressure were transferred
to recipient SMCs. We counted cells after 5 days of incubation with these media and evaluated eNOS and inducible NOS
(iNOS) levels by Western blot.
Results: Conditioned media from pressurized endothelial cells significantly decreased recipient SMC counts. This effect
was sustained when N-nitro-L-arginine-methyl ester (L-NAME) was added to recipient cells but abolished when
L-NAME was added to donor cells. SMCs were then exposed to control and pressurized conditions in monoculture or in
coculture with endothelial cells. Pressure and coculture caused similar increase in iNOS levels but had no additive effect
in combination. Finally, endothelial cells were exposed to control and pressurized environments. Pressure caused a 24%
1.6% increase in eNOS protein (P  .04, n  12). This effect was sustained when cells were treated with L-NAME
(32% 1.6% increase, P .02) but abolished when endothelial cells were treated with calphostin C or PD98059 to block
protein kinase C (PKC) or extracellular regulated kinase (ERK). Pressure also increased endothelial phosphorylated ERK
(p-ERK) by 1.8-fold to 2.6-fold compared with control conditions after exposure of 2, 4, and 6 hours (P  .02, n  4).
This increase was sustained after pretreatment with calphostin C.
Conclusion: Pressure modulates endothelial cell effects on SMC growth by increasing eNOS in an ERK-dependent and
PKC-dependent manner. (J Vasc Surg 2006;44:1076-84.)
Clinical Relevance: Intimal hyperplasia is the main cause for restenosis that complicates 10% to 30% of all such vascular
procedures and 30% to 40% of endovascular procedures. This article provides some novel information about smooth
muscle cell/endothelial cell interaction, one of the main regulators of vascular remodeling and intimal hyperplasia. The
role of endothelial cell/smooth muscle cell interaction cannot be studied well in vivo because these interactions cannot be
distinguished from other factors that coexist in vivo, such as flow dynamics, matrix proteins, inflammatory factors, and
interactions with other cells in the vascular wall and in the bloodstream. In this work, we use pressure as a triggering
stimulus to alter in vitro endothelial behavior and identify important changes in endothelial regulation of smooth muscle
cell biology. The pathways involved in this process and discussed in this article could ultimately be used to manipulate
endothelial cell/smooth muscle cell interaction in clinical disease.Despite significant medical advances, intimal hyperpla-
sia remains a major cause of failure of endovascular and
vascular reconstructions. Although numerous factors affect
intimal hyperplasia, endothelial (EC) and vascular smooth
muscle cell (SMC) interaction may be one of the most
significant. The in vivo study of EC/SMC cross-talk is
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1076complex because it is impossible to separate the pure effects
of EC/SMC interaction from all the other dynamic, hu-
moral, cellular, and inflammatory factors that coexist in
vascular environments in vivo. In vitro studies that use
coculture models could theoretically achieve such separa-
tion; however, in most such models, ECs paradoxically
stimulate SMC migration1-4 and increase SMC prolifera-
tion.5-7 In other words, in conventional coculture, ECs
exhibit an aggressive form different from what is usually
observed in vivo. In vitro, cocultured ECs promote rather
than control SMC growth.1,2
We recently created a pressurized coculture model to
study EC interaction with SMC in a pressurized environ-
ment. Pressure is known to affect EC growth in a bimodal
fashion. Typically, ECs at lower pressures (60 mm Hg,
/20 mm Hg, 100 mm Hg,/60 mm Hg or 80 mm Hg)
proliferate more rapidly than ECs in atmospheric pressure,
whereas higher pressures (cyclic 140 mm Hg/100 mm Hg
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exposed EC/SMC cocultures to 130 to 135 mm Hg
ambient pressure, choosing in this way to study the inhib-
itory growth effect of pressure in the context of coculture in
an effort to delineate pathways that might prevent intimal
hyperplasia.
Our laboratory has previously developed an EC/SMC
coculture model by plating SMCs in six-well plates and
placing inserts on top of these wells. The inserts have
endothelial cells growing on semipermeable membranes
that pass nutrients but do not allow cell contact. In this
way, ECs and SMCs share the same media and can have
humoral interaction but cannot physically touch each
other. Using this model, we have previously reported that
cocultured SMCs in ambient environment grew more rap-
idly than monocultured SMCs. When cocultured SMCs
were placed in a high-pressure environment, the growth-
promoting effect caused by ECs was reversed.9
Pressurized cocultured SMC exhibited decreased cell
counts by Coulter counter compared with cell counts ob-
served in pressurized monocultured SMC, ambient pres-
sure monocultured SMC, or pressurized SMC in coculture
with ECs. This decrease in cell counts was accompanied
with decreased c-myc levels in pressurized cocultured
SMCs, suggestive of decreased proliferative activity.10 The
same pressurized cocultured SMCs also exhibited increased
apoptotic activity assessed by terminal deoxynucleotide
transferase-mediated dUTP nick-end labeling (TUNEL)
staining fluorescence microscopy as well as acridine-orange
staining.10,11
A similar growth pattern was reproduced in recipient
SMCs in ambient pressure when conditioned media from
control ECs, pressurized ECs, and control and pressurized
SMC donor cultures were transferred to the recipient
SMCs.10 In such studies, media from control ECs caused
the highest increase in growth, and media from pressurized
ECs cause the most prominent growth inhibition in the
recipient SMCs.10 These previous data suggests that pres-
sure converts the endothelial behavior towards the cocul-
tured SMC from an aggressive one seen in conventional
in vitro environment to a regulatory, vessel-friendly one
seen in our pressurized model.
In the present article, we report our test of the hypoth-
esis that this transferable factor is some molecule related to
nitric oxide (NO), postulating that the dramatic effects
seen in pressurized coculture are more due to endothelial
changes by pressure than due to myocytic humoral changes
by pressurized coculture. We assessed indirectly the effects
of pressure and EC coculture on NO, a significant effector
known to be influenced by mechanical forces.12,13 We
focused on endothelial nitric oxide synthase (eNOS) and
inducible NOS (iNOS) regulation and evaluated NOS
levels in EC cultures and SMC monocultures and cocul-
tures (with EC) in different pressure environments. We also
evaluated the effect of NOS activity inhibition by N-nitro-
L-arginine-methyl ester (L-NAME) on the effects of con-
ditioned medium from pressurized ECs and SMCs that is
then transferred to separate SMC monocultures.Finally, we hypothesized that if eNOS was changed by
pressure, this effect might be mediated by extracellular
regulated kinase (ERK) or protein kinase C (PKC) activa-
tion, since the literature suggests that vascular and other
cells respond to mechanical stimuli such shear stress and
strain through mitogen-activated protein kinase (MAPK)
or PKC activation.14-16 We performed additional studies to
test this further hypothesis.
MATERIALS AND METHODS
Pressure apparatus. The chamber used for pressur-
ized cultures has been described elsewhere.10 This is a
custom-made chamber made of stainless steel that fits into
a cell culture incubator. A carefully regulated gas mixture
creates a humidified culture environment with 5% carbon
dioxide at 37°C. The pressure levels in the pressure cham-
ber can be easily adjusted according to the experimental
design and were set here at 130 to 135 mm Hg. The
literature suggests that pressure affects ECs in a bimodal
fashion. Typically, ECs at lower pressures (60 mm Hg/
20 mm Hg, 100 mm Hg/60 mm Hg or mean 80 mm
Hg) proliferate more rapidly than ECs in atmospheric
pressure, whereas higher pressures (cyclic 140 mm Hg/
100 mm Hg or static 100 to 160 mm Hg) inhibit EC
growth.8 The inhibitory effect of high pressure at 130 to
135 mm Hg has been validated in our model in previous
experiments.10 We therefore now used the same pressure
regimen to test the hypothesis underlying the present in-
vestigation. Pressure was constantly measured by an analog
pressure monitor. Chamber conditions were monitored in
both pressure environments with regular media testing for
pH and pCO2.
Cell cultures. Rat aortic endothelial and smooth mus-
cle cells were harvested and grown (8 to 15 passages) from
primary culture in Dulbecco Modified Eagle’s Medium
(DMEM) supplemented with penicillin, streptomycin, and
10% or 5% calf serum.
EC/SMC cocultures. The coculture model has been
described previously.9,10 In this project, we used the cocul-
ture model only for the experiments designed to measure
iNOS levels. In brief, endothelial cultures were established
by plating ECs on a 15-m-thick polycarbonate membrane
with 3.0-m pores (Corning Costar Brand Transwell Plate
inserts, Corning, NY) at a subconfluent density of 150,000
cells/well. SMCs were plated separately at density of
50,000-cells/well on six-well plates (Corning). After over-
night incubation, the inserts with attached ECs were trans-
ferred to six-well plates to form EC/SMC cocultures.
SMC cell baseline density was assessed by cell counting
with a Coulter counter before coculture formation at day 0.
One milliliter of complete medium was placed in each insert
and 2 mL in each coculture well, and 3 mL of complete
medium was placed in each well of independent SMC
culture. The SMCs were not in direct contact with the ECs,
but they shared the same media and nutritional factors.
Studies with conditioned media. Smooth muscle
and endothelial cells were seeded in T-75 flasks, treated
with fresh media containing 10% fetal bovine serum, and
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then changed to 8 mL of new medium containing 5% fetal
bovine serum, and flasks were then maintained at control
ambient pressure or in pressurized (130 to 135 mm Hg)
chambers. We chose to expose donor cells to pressure for 5
days, because in previous work,9,10 we achieved maximal
difference in cell counts or TUNEL-positive cell counts in
pressurized EC/SMC cocultures after exposing the cells to
pressure for 5 days.
No media changes were performed during this period.
Pressurized and ambient donor ECs and SMCs in T-75 flasks
were treated separately with 2.5 to 5 mM of L-NAME, which
inhibits eNOS activity and NO formation. In choosing
to study the effects of 2.5 to 5 mM L-NAME, we were
guided by other authors’ reports of similar experiments
with L-NAME using similar coculture models.17 We tested
2.5 mM and 5 mM concentrations. In each case, we ob-
served similar responses and did not observe obvious toxic
effects in either endothelial or smooth muscle cell cultures.
There were no floating cells, and a lactate dehydrogenase
activity assay showed that lactate dehydrogenase activity
was not increased.
In addition, cells treated with L-NAME exhibited sim-
ilar if not higher cell counts than control cells. Conditioned
medium at the end of the 5-day period was diluted 8:1 with
fresh medium (5% fetal bovine serum) and transferred to
six-well plates containing recipient SMCs plated overnight
at 10,000 cells/well. Conditioned medium was changed
every other day. Recipient SMCs were treated for 5 days. At
the end of this period, recipient SMCs were trypsinized,
and cell number was assessed by counting cells using a
Coulter counter.
Western blot analysis for iNOS and eNOS. In pre-
vious work, decreases in cell counts of the cocultured SMCs
occurred on day 3 and were maximal on day 5 of exposure to
pressure. We observed a similar pattern when we evaluated
SMC apoptosis by TUNEL.9,18 We believe that pressure-
induced changes in intracellular and intercellular signals,
including changes in eNOS/iNOS, must occur earlier than
the maximal effects on cell number or apoptosis, or both, if
they are to mediate these effects. We therefore measured
eNOS and iNOS levels at day 3.
We first evaluated iNOS regulation by pressure, EC
coculture, or the combination of pressure and coculture by
exposing SMCs to four conditions: (1) monocultures in a
control environment (SMC/0), monocultures at 130 to
135 mm Hg pressure (SMC/0-P), EC coculture in control
environment (EC/SMC), and pressurized EC coculture at
130 to 135 mm Hg (SMC/EC-P).
SMC proteins were isolated by scraping SMC at 4°C
using 30 L of a commercially available preparation of
protease inhibitors that contains AESBF-[4-(2-aminoethyl)
benzenesulfonyl fluoride hydrochloride]-serine proteases,
aprotinin, bestatin hydrochloride, E-64-[n(trans-epoxy-
succinyl)-L-leucine 4 guanidinobutylamide], and pepstatin
(100 L/3 wells, Sigma/Aldrich # P8340, St. Louis, Mo)
mixed with 3 mL of the lysis buffer.Cells were homogenized for 1 minute, and then incu-
bated at 4°C. Protein content was quantified by spectropho-
tometry. Samples (with equal protein content) were resolved
on 10% polyacrylamide gels and electrophoretically trans-
ferred to polyvinylidene difluoride (PVDF) membranes (Mil-
lipore, Bedford, Mass). Membranes were incubated overnight
at 4°C with 5% milk in phosphate-buffered saline (PBS) to
block nonspecific binding sites, rinsed in 0.1% Triton
X-100 in PBS (PBST), and incubated for 2 hours with
primary antibody against rat iNOS (Santa Cruz Biotechnol-
ogy Inc, Santa Cruz, Calif) diluted at 1:200 to 1:300. Blots
were then rinsed for 10 minutes three times with PBST and
incubated in secondary antibody (1:1000 in 5% milk) for 1
hour. After washing the membranes again three times in
PBST for 10 minutes, we visualized antibody binding using
the enhanced chemiluminescence method (Pierce, Rock-
ford, Ill). For quantification, films were digitally scanned
using a ScanJet 6300C scanner (Hewlett Packard, Palo
Alto, Calif).
Membranes were also stripped and reprobed for actin.
Actin band density then served as a protein loading control.
Image scans were analyzed with the UN-SCAN-IT gel
Automated Digitizing System 5.1 (Silk Scientific, Inc,
Orem, Utah). Protein band density was normalized accord-
ing to actin band density derived from the analysis of the
same endothelial or myocytic protein. All exposures used
for analysis were within the linear range of the system.
In separate studies, we evaluated eNOS regulation by
pressure in endothelial cells. For these studies, we compared
ECs monocultured under control or 130 to 135 mm Hg
pressure for 3 days. EC cultures were treated with: (1) dimeth-
ylsulfoxide (DMSO) (control), (2) 100 nM of light-activated
calphostin C, a specific PKC inhibitor, (3) 20 M of
PD98059 an inhibitor of MEK (mitogen activated ERK-
activating kinase) activity that prevents subsequent ERK acti-
vation, or (4) 2.5 mM L-NAME to inhibit NO. Endothelial
protein was harvested on day 3 using the same protocol used
for myocytic protein and then analyzed for eNOS after a
2-hour incubation in primary antibody against rat eNOS
(1:200 dilution; Santa Cruz Biotechnology), followed by a
1-hour incubation in secondary antibody (1:1000 dilution
in 5% milk).
Western blot analysis for phosphorylated (acti-
vated) ERK. Endothelial cells were exposed to ambient
and high pressure (130 to 135 mm Hg) for 2, 4, and
6 hours before analysis for activated phosphorylated-ERK
(p-ERK) and ERK protein. Protein was harvested using the
previously described protocol. Cellular protein was then
resolved by sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS-PAGE), transferred to PVDF membranes, and
probed with antibodies specific for the phosphorylated forms
of ERK1/2 (pERK1/2, dilution 1:1000; Cell Signaling
Technology, Danvers, Mass) to determine the activation
status of ERK by pressure. As a control, the total amount of
ERK1/2 was determined by Western blot analysis using an
anti-ERK1 antibody that also cross-reacts with ERK2 (1:
1000; Cell Signaling Technology). Goat anti-rabbit immu-
noglobulin G conjugated to alkaline phosphatase was used
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by a chemiluminescent detection method as explained
above. The band density ratio of activated content of
ERK1/2 to total ERK from each condition was also nor-
malized to this first experimental condition (2 hours of
exposure to no pressure).
In separate experiments, ECs were treated with 100 nM
of DMSO (control) or light-activated calphostin C (to
achieve PKC inhibition) and exposed to ambient pressure
and a high-pressure environment for 4 hours. Western blot
analysis of the endothelial protein assessed the effect of
calphostin C on ERK1/2 activation in these two different
pressure conditions.
Statistical analysis. Each experiment involving cell
counts was done in independent triplicate wells. The cell
count/well reflects the arithmetic average from three to
four counts by Coulter counter. Each experiment was
repeated three times for nine separate and independent
results, which were considered as n  9 and pooled for
statistical analysis. Western blot analysis for each separate
experiment was repeated between 4 and 12 times, depend-
ing upon the particular study. Data are expressed as 
SEM. Western blot for iNOS was repeated three times;
however, the observed difference reached statistical signif-
icance at P  .01.
For the studies involving conditioned media and cell
counts, two comparisons were performed separately in the
control and L-NAME group. The first comparison was
between the SMCs treated with media from control SMCs,
and SMCs treated with media from pressurized SMCs. The
second comparison was between SMCs treated with media
from control ECs, and SMC treated with media from
pressurized ECs. This set of studies was analyzed by t test
with Bonferroni correction for multiple tests. According to
the Bonferroni correction for two comparisons, values of
P .018 were considered statistically significant. Statistical
analysis of the Western blots was performed using t test
with Mann-Whitney modification or analysis of variance
(ANOVA) as applicable. P  .05 was considered statisti-
cally significant.
RESULTS
Nitric oxide inhibition attenuates growth inhibi-
tory properties of pressurized ECs. We first performed
control studies with SMCs treated with conditioned media
from atmospheric (nonpressurized) SMCs and ECs and
media from pressurized ECs and SMCs. Media from pres-
surized ECs decreased the cell count of SMCs by 33.5%
compared with the effects on SMC cell counts of media
from control ECs. This difference was statistically signifi-
cant (P  .01, n  9) (Fig 1, a). The results from these
control groups are consistent with previous published ob-
servations.9,10
This pressure-induced, endothelially derived, growth-
inhibiting effect was abolished when donor cells were pre-
treated with L-NAME (P  .8, n  9) (Fig 1, b). The
growth inhibiting effect persisted when L-NAME was
added to recipient cells (Fig 1, c). Pressure caused nochanges in the trophic properties of the conditioned media
that were originally derived from SMC. L-NAME did not
alter this effect.
In previous articles, we observed that pressure de-
creases the growth of EC-cocultured SMCs. This growth
effect was also reproduced in separate SMC cultures treated
with conditioned media from pressurized ECs.10 Taking
these previous observations together with this new result
suggests that the growth-inhibiting transferable factor is
blocked by eNOS inhibition in donor ECs and not affected
by blocking iNOS in the recipient cultures.
Pressure induces eNOS in a PKC-dependent and
ERK1/2-dependent manner. Because NO seemed a
likely candidate to contribute to the trophic effect of pres-
surized ECs on SMC growth, we sought to determine
whether pressure induces eNOS and whether PKC or ERK
activation could contribute to this effect. We did not directly
measure NO but concentrated on investigating eNOS regu-
Fig 1. Conditioned media from pressurized endothelial cells
(EC-P) decreased the cell counts of recipient smooth muscle cell
(SMC) cultures compared with conditioned media from ambient
endothelial cells (EC) (P .001). Media from atmospheric (SMC)
and pressurized (SMC-P) had similar effect (a). This reversed
trophic effect of conditioned medium from EC-P was abolished
when the donor cells were pretreated with 2.5 to 5 mM of
N-nitro-L-arginine-methyl ester (L-NAME) a nitric oxide inhibi-
tor (b). The addition of L-NAME to pressurized endothelial
media after its removal from the recipient cells had no effect on the
properties of the pressurized media (c). Data are expressed as 
SEM.lation by pressure. Fig 2, A demonstrates a typical Western
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conditions treated with DMSO (control), calphostin C
(PKC inhibitor), PD98059 (MEK inhibitor that prevents
ERK activation), or L-NAME. Fig 2, B summarizes the
densitometric analysis of 12 similar Western blots. Expo-
sure to a high-pressure environment increased the levels of
endothelial eNOS by 24%  1.6% (P  .04, n  12). This
effect did not change when cells were treated with L-
NAME, (32%  1.6% increase, P  .02); however, the
effect of pressure on eNOS was abolished when ECs were
treated with calphostin C or PD98059.This observation
suggested that pressure-induced upregulation of eNOS
requires ERK and PKC activity.
Pressure and coculture and their combination pro-
mote myocytic NOS similarly. We sought in parallel to
assess how SMC iNOS is regulated by pressure or EC
coculture, or both. We measured iNOS protein levels via
Western blots of SMC protein derived from SMCs grown
in control conditions (SMC/0), in coculture with ECs in
control conditions (SMC/EC), from SMCs exposed to
pressure (SMC/0-P), and from SMCs in pressurized cocul-
Fig 2. Endothelial cell (EC) protein exposed to ambient (NP) and
135 mm Hg pressure (P) was analyzed for endothelial nitric oxide
synthase (eNOS). Endothelial cells were treated with dimethylsulfox-
ide (DMSO) (vehicle control), calphostin C (CalC) to block protein
kinase C, PD98059 (PD) to block extracellular signal-regulated ki-
nase, or N-nitro-L-arginine-methyl ester (L-NAME) to inhibit
nitric oxide. A, Shows typical western blot for eNOS from EC
protein from ambient and high-pressure conditions. B, Pressure
increased eNOS in the control and L-NAME group (*P .04 and
**P  .02, n 12). Calphostin C and PD98509 blocked this
effect, suggesting that pressurized EC exhibit increased levels of
eNOS via a PKC and ERK dependent pathways. Data are expressed
as  SEM.ture with ECs (SMC/EC-P). Application of pressure or thepresence of endothelial cells similarly increased 2.5-fold
(P .05) myocytic iNOS compared with baseline iNOS in
monocultured SMC at ambient pressure (SMC/0). How-
ever, combining both coculture and increased pressure
(SMC/EC-P) had no additive effect on the protein in-
crease (Fig 3).
We have previously9,10,17 demonstrated that cocul-
tured SMCs in pressurized EC/SMC cocultures exhibit
dramatically decreased proliferative and enhanced apopto-
tic activity compared with monocultured control SMCs
and also compared with EC-cocultured SMCs at ambient
pressure and monocultured pressurized SMCs. Because we
now demonstrate that iNOS levels do not change among
cocultured, pressurized, and pressurized cocultured SMC,
it seems likely that the increased SMC apoptosis and decel-
erated SMC proliferation in pressurized SMC coculture
that we had previously described in comparison with all
three other SMC groups may be linked to upregulated
eNOS levels in pressurized ECs and cannot be explained by
myocytic iNOS regulation.
Pressure induces early phosphorylation of ERK1/2
in a PKC-independent manner. To further investigate
the pressure regulation of endothelial ERK, we analyzed
endothelial protein harvested from endothelial cells ex-
posed to atmospheric pressure or to 135 mm Hg for 2, 4,
and 6 hours. ERK activation in response to various stimuli
has been described either downstream of PKC activation or
independent of the PKC pathway.19-24 To explore these
two possibilities, we treated ECs with DMSO (control) or
light-activated calphostin C before exposure to pressure
and assay for ERK activation.
A typical Western blot analysis for p-ERK1 and
p-ERK2 is shown in Fig 4, A. Total ERK levels were
constant throughout all conditions consistently in all
four experiments. However, we observed increased acti-
Fig 3. Smooth muscle cell (SMC) protein was analyzed for in-
ducible nitric oxide synthase (iNOS). Endothelial cell (EC) cocul-
ture and pressure increased to a similar degree iNOS levels. How-
ever, the combination of the two conditions in the form of
pressurized coculture had no additive effect on iNOS (*P  .01
bars 2, 3, and 4 vs first bar, n  3 experiments). SMC/0, SMCs
grown in control conditions; SMC/EC, SMCs in coculture with
ECs; SMC/0P control SMCs exposed to pressure; SMC/EC-P,
SMCs in pressure coculture with ECs. Data are expressed as 
SEM.vation of ERK1 and ERK2 (p-ERK 42 and 44) in re-
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exposure. Fig 4, B summarizes the densitometric assess-
ment of activated ERK expressed as the ratio of p-ERK to
total ERK normalized to the densitometric ratio ob-
tained from the first condition (2 hours of ambient
pressure). At each time point, 130 to 135 mm Hg of
pressure caused a 1.5-fold to 2.3-fold increase in p-ERK
(42 and 44) compared with ambient pressure (ANOVA
P  .02; n  4).
In separate experiments, PKC activation was inhibited
by treating cells with calphostin C and exposing them to
ambient and high pressure for 4 hours. PKC inhibition did
not decrease the pressure-induced activation of ERK
(p-ERK expression). We noticed a fivefold increase of
p-ERK by high pressure in ECs treated with calphostin C
(P  .05 ANOVA, n  4) (Fig 5). This suggests that
although pressure increases eNOS through activation of
ERK and PKC, PKC activation does not affect ERK. Thus,
in these particular conditions in ECs, ERK activation in
response to increased pressure is not an event downstream
of PKC activation.
DISCUSSION
In this study, we have been able to better elucidate the
pressure-induced events that may modulate SMC prolifer-
ation and EC and SMC interaction in a pressurized cocul-
ture model. Specifically, we observed that pressure causes
pressurized ECs to produce transferable mediators that,
through conditioned media, decrease the cell count of
recipient SMCs compared with conditioned media from
ECs grown in ambient conditions. This paracrine effect
Fig 4. A, Typical Western blot analysis and summary of four such
Western blots of endothelial protein exposed for 2, 4, and 6 hours
to control pressure (NP) and high pressure at 130 to 135 mm Hg
(P). B, Pressure in each time-point increased activated phosphor-
ylated extracellular signal-regulated kinase (p-ERK) 1/2 content
over total ERK1/2 compared with control conditions (*P  .02,
analysis of variance, n  4). Data are expressed as  SEM.seems likely to be NO-dependent, because the antiprolif-erative effect of pressurized conditioned media is abolished
when donor ECs are treated with L-NAME. Furthermore,
pressure increased eNOS levels in pressurized ECs, through
the independent activation of ERK and PKC. ERK activa-
tion was not PKC-dependent.
Role of myocytic NOS in pressurized and cocul-
tured SMC growth changes. Myocytic NO regulation
does not seem to be a major growth effector in our cocul-
ture model, or at least is not likely to be linked to the
pressure-induced changes observed in endothelially cocul-
tured SMCs. Although pressure and endothelial coculture
do cause iNOS induction in SMCs compared with baseline
conditions, the intensity of this effect is similar in both
conditions. Moreover, the combination of both conditions
in the form of pressurized coculture does not cause any
additional increase in iNOS levels (Fig 3). This similar
iNOS induction in all three conditions compared with
control SMC growing in monocultures in a control pres-
sure (baseline) environment does not correlate with the
observation that each one of these conditions influences
SMC proliferation and apoptosis differently, leading to
growth promotion in EC-cocultured SMCs, no significant
growth change in pressurized SMCs, and maximal growth
inhibition in pressurized cocultured SMCs.9,10 Thus, iNOS
changes are probably not responsible for the different
growth patterns displayed by pressurized, cocultured, and
pressurized-cocultured SMC.
NOS induction by pressure and endothelial cells.
Fig 5. Summary of 4 similar Western blot analyses for phosphor-
ylated extracellular signal-regulated kinase (p-ERK) from endo-
thelial cells exposed to ambient (np) and 130 to 135 mm Hg
pressure (p) for 4 hours. Cells were treated with 100 nm calphostin
C (Cal-C) to block protein kinase C activation. Control cells were
treated with dimethylsulfoxide. Each Western blot demonstrated a
similar effect: endothelial cell treatment with calphostin C does not
attenuate the increase in ERK activation by pressure. Indeed, there
is a fivefold increase in p-ERK in pressurized endothelial cells
treated with calphostin C compared with levels of ERK activation
in endothelial cells treated with calphostin C at ambient pressure
(P .05 by analysis of variance). These findings suggest that pressure-
induced ERK activation is independent of protein kinase C.In vivo, NO is produced mainly in constitutive form by
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other cells. NO regulates vascular tone,25 downregulates
endothelin,26 increases SMC apoptosis,16,27,28 and de-
creases SMC proliferation.27,29,30 Shear stress, cyclic strain,
and repetitive deformation31,32 consistently induce NO
directly or increase NOS levels from vascular cells. How-
ever, the effects of pure pressure on NO induction outside
the context of clinical hypertension are not well under-
stood. Our data suggest that pressure induces not only
eNOS but also iNOS synthesis in SMCs. Moreover, it is
interesting that the sole presence of ECs causes induction
of iNOS in cocultured SMCs. This effect could be mediated
through endothelin activation, as iNOS stimulation by
endothelin has been observed in other cell types such as
chondrocytes and primary glial cells.33-36
The NO effect is transferable through endothelially
conditioned medium. Conditioned media from pressur-
ized ECs exerts growth-inhibitory effects on recipient
SMCs compared to the effects of media from control ECs.
This transferable growth-inhibitory effect is abolished
when donor cells are treated with L-NAME. Thus, the
transferable factor from pressurized ECs that causes SMCs
not to grow is probably linked to eNOS activity. NO is
probably the responsible initial pressure-induced mediator,
although we have not measured NO levels in our system.
However, NO is not transferable through the conditioned
media because it is a very unstable molecule with a half-life
of only 2 to 4 seconds before it converts to an inactive
molecule. Thus, NO is not likely to be maintained in active
form in conditioned media.
The transferable factor actually present in the media of
pressurized ECs is likely to be some other factor regulated
by endogenous NO. This factor is derived from ECs and
not from SMCs, because media from pressurized myocytes
causes no change in the growth pattern of recipient cells
compared with myocytic media from control conditions.
Furthermore, pretreatment with L-NAME does not affect
the mitotic properties of the SMC-derived media. Further
characterization of this endothelial transferable factor war-
rants future investigation.
Finally there is a significant body of emerging literature
demonstrating the effects of peroxynitrites on vascular cells.
These extremely unstable molecules are produced during
conditions of increased oxidative stress. Peroxynitrites are
known to cause accelerated SMC apoptosis and play a
significant role in vascular remodeling.37 Although other
mechanical forces such as shear stress38,39 are known to
cause oxidative stress, the effects of pressure on oxidative
stress is not yet known. It is quite likely though that
peroxynitrites produced by pressurized ECs may play a role
in our system. However because these molecules are very
unstable, they cannot be maintained in the conditioned
media and thus if they do cause changes in our system, these
changes occur through the regulation of another more
stable transferable intermediate factor.
Endothelial NOS dependence on ERK and PKC
pathways. Our present results suggest that both PKC and
ERK1/2 activation are likely to be involved in mediatingthe pressure effect on eNOS. Moreover, in contrast to some
previous reports in response to other stimuli, pressure-
induced endothelial ERK1/2 activation does not seem to
require PKC activation.
PKC affects eNOS and NO activity in opposite ways in
different settings. PKC activation may inhibit NO re-
lease.40-42 However, PKC activation induced mechanically,
hypoxically, or through platelet-derived growth factor may
induce eNOS synthesis or NO release in endothelial and
other cells,43-45 in a manner similar to our observations.
Our results also suggest that pressure activates
ERK1/2 that then induces eNOS. ERK phosphorylation
usually occurs via a PKC-dependent pathway21,46 and a
PKC-independent pathway.47 Mechanical stresses such as
shear stress and cyclic strain have been reported to cause
ERK activation via PKC-dependent pathways43,48,49 that
lead to cell proliferation. In our model, however, pressure-
induced activation occurs through a PKC-independent path-
way. This observation is consistent with other reports of
pressure-induced ERK activation in pressurized rabbit aortic
tissue ex vivo through a PKC-independent pathway.50
We studied pressure and coculture-induced NO-
related effects on SMC indirectly by assessing regulation of
eNOS and iNOS expression. We have not directly assayed
NO release or NOS activation, nor have we evaluated other
potentially important signals that also induce NOS activa-
tion in response to other stimuli and might be relevant
here. For instance, the PI3-kinase-Akt pathway is sensitive
to mechanostransduction,51,52 activates NO release by
phosphorylating eNOS,53 and influences ET1-induced
NOS via the p38 pathway.54 This could also conceivably be
involved in the effects described here, because we believe
that ET1 may be responsible for the iNOS increases caused
by EC coculture (Fig 3). Similarly PKA is also sensitive to
mechanotransduction but causes eNOS activation and NO
release in a PI3-AKT–independent pathway.55 Finally
other pathways induced by mechanotransduction (shear
stress), such as Src that induces eNOS expression,56 but not
eNOS activation and NO release,39 have also not been
examined in our coculture model. Future studies will be
necessary to determine whether these other signal proteins
might also be important in our system.
CONCLUSION
Our results demonstrate that pressure increases eNOS
levels in pressurized ECs though activation of separate PKC
and ERK signals. These changes seem to affect the para-
crine properties of EC, enhancing the ability of ECs to
inhibit SMC growth. These observations emphasize the
likely importance of extracellular pressure as an indepen-
dent effector of vascular endothelial behavior and the dif-
ferences in mechanotransduction of pressure effects on EC
compared with the effects of shear stress and strain. In
previous studies, we have seen that pressure causes unique
effects on endothelial and smooth muscle cells, increasing
apoptosis and decreasing EC and SMC proliferation9,10,18
in a manner opposite to the predominantly trophic and anti-
apoptotic effects of cyclic strain as extrapolated from vast
JOURNAL OF VASCULAR SURGERY
Volume 44, Number 5 Vouyouka et al 1083literature dedicated to cyclic strain.51,57-59 In this study, we
saw that ERK1/2 activation was induced through a different
pathway. Thus, we believe that pressure as a separate hemo-
dynamic entity merits more thorough investigation. Be-
cause EC/SMC interactions are important regulators of
atherogenesis in vivo, PKC-dependent and ERK-depen-
dent stimulation of endothelial NO release in response to
extracellular pressure may play an important role in vascular
remodeling and the formation of intimal hyperplasia.
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